N@N

Market Maker Surveillance Report. CETV, CT, OCLS, LXRX, HGSH, LAS, Losing Stocks With Lowest Price Friction For Monday, April

April 29, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3676 companies with "abnormal" market making, 3628 companies with positive Friction Factors and 1763 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Central European Media Enterprises Ltd (NASDAQ:CETV), Capital Trust Inc (NYSE:CT), Oculus Innovative Sciences Inc (NASDAQ:OCLS), Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), China Hgs Real Estate Inc (NASDAQ:HGSH), Lentuo International Inc (NYSE:LAS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CETV    $-0.540   -12.39%   135,602      44.81%    167,011      55.19%    -31,409      -582    
  CT      $-0.270   -10.76%   107,737      36.80%    113,094      38.63%    -5,357       -198    
  OCLS    $-0.960   -17.36%   69,969       48.63%    73,806       51.30%    -3,837       -40     
  LXRX    $-0.310   -13.45%   2,283,129    46.28%    2,606,962    52.84%    -323,833     -10,446 
  HGSH    $-2.880   -23.55%   107,220      41.72%    147,178      57.26%    -39,958      -139    
  LAS     $-0.830   -31.68%   140,683      31.93%    154,095      34.97%    -13,412      -162    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows CETV with a dollar loss Monday of $-0.54000 and a Friction Factor of -582 shares. That means that it only took 582 more shares of selling than buying to move CETV lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Central European Media Enterprises Ltd (NASDAQ:CETV) - Central European Media Enterprises Ltd., a media and entertainment company, operates broadcast, content, and new media businesses in central and eastern Europe. The company operates in three segments: Broadcast, Media Pro Entertainment, and New Media. The Broadcast segment operates 36 television channels reaching an aggregate of approximately 50 million people primarily in 6 countries. Its television channels comprise BTV, BTV CINEMA, BTV COMEDY, RING.BG, BTV ACTION, and BTV LADY, a female-oriented cable channel in Bulgaria; NOVA TV, DOMA, and NOVA WORLD in Croatia; TV NOVA, NOVA CINEMA, NOVA SPORT, MTV CZECH, FANDA, SMICHOV, and TELKA in the Czech Republic; and PRO TV, PRO TV INTERNATIONAL, ACASA, ACASA GOLD, PRO CINEMA, MTV ROMANIA, PRO TV CHISINAU, and SPORT.RO in Romania. This segment s television channels also consist of TV MARK ZA, DOMA, DAJTO, and FOOOR in the Slovak Republic; and POP TV, KANAL A, and POP NON STOP, a subscription package of six channels that includes POP KINO, POP KINO2, POP BRIO, POP FANI, POP OTO, and POP SPOT in Slovenia, as well as various radio channels in Bulgaria. The Media Pro Entertainment segment develops, produces, and distributes content for its own television channels, as well as to third parties through the theatrical and home video operations; sells DVD and Blu Ray discs to wholesale and retail clients; and distributes theatrical, home entertainment, digital, and television film rights. This segment also owns and operates 11 cinema screens in Romania. The New Media segment offers television content through its video-on-demand service, Voyo; and operates various news portals, niche Websites, and television-related Websites. Central European Media Enterprises Ltd. was founded in 1994 and is based in Hamilton, Bermuda..

Capital Trust Inc (NYSE:CT) - Capital Trust, Inc., a real estate investment trust, operates as a real estate finance company that provides credit sensitive financial products in the United States. The company s investment programs focus on loans and securities backed by commercial real estate assets, including mortgage loans, property and corporate mezzanine loans, commercial mortgage backed securities, and subordinate mortgage interests. Its balance sheet investments include various types of commercial mortgage backed securities and collateralized debt obligations or securities, and commercial real estate loans and related instruments. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Capital Trust, Inc. was founded in 1966 and is headquartered in New York, New York..

Oculus Innovative Sciences Inc (NASDAQ:OCLS) - Oculus Innovative Sciences, Inc. designs, produces, and markets drugs, devices, and nutritional products based on its Microcyn platform technology for the dermatology, surgical, wound care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. Microcyn platform technology is based on electrically charged oxychlorine small molecules that target a range of disease causing organisms, which include viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in wounds, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human wound and skin care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand name. The company also offers Glucorein Green Tea with chlorogenic acid, a medical food for the dietary management of glucose levels in pre-diabetics and type 2 diabetics. Its Microcyn has received seven 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, the company provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. It sells its products to hospitals, physicians, nurses, and other healthcare practitioners who are the primary caregivers to patients being treated for acute or chronic wounds or undergoing surgical procedures, as well as to dermatologists for the treatment of various skin afflictions. Oculus sells its products directly, as well as through contract sales organization and distributors. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is based in Petaluma, California..

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) - Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for human disease. Its portfolio of drug programs in various stages of clinical development include LX4211, a dual inhibitor of sodium-glucose cotransporters 1 and 2, which is in Phase IIb clinical trials for the treatment of type 2 diabetes; LX1032, an inhibitor of tryptophan hydroxylase, is preparing for Phase III registrational trials to reduce peripheral serotonin production without affecting brain serotonin levels in patients with carcinoid syndrome, as well as initiated a Phase II proof-of-concept trial for patients with ulcerative colitis; and LX1033, a serotonin synthesis inhibitor that is in Phase II clinical trials for the treatment of irritable bowel syndrome. The company also develops LX2931, an inhibitor of sphingosine-1-phosphate lyase, which completed a Phase IIa clinical trials and conducting a dose-ranging study to explore higher doses as a treatment for rheumatoid arthritis and other autoimmune diseases; and LX7101, an orally-delivered small molecule compound that initiated a Phase I-II proof-of-concept study in glaucoma patients. It also has advanced small molecule compounds from various additional drug programs into various stages of preclinical development and research. The company has drug discovery and development collaborations with Bristol-Myers Squibb Company; Genentech, Inc.; Schering-Plough/Organon; and Takeda Pharmaceutical Company Limited. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas..

China Hgs Real Estate Inc (NASDAQ:HGSH) - China HGS Real Estate Inc., through its subsidiary, Shaanxi Guangsha Investment and Development Group Co., Ltd., engages in the real estate development in the People s Republic of China. It is involved in the construction and sale of residential apartments, car parks, and commercial properties. The company develops commercial and residential projects, including multi-layer, sub-high-rise, and high-rise apartment buildings, as well as office buildings. China HGS Real Estate Inc. was founded in 1995 and is headquartered in Hanzhong, the People s Republic of China..

Lentuo International Inc (NYSE:LAS) - Lentuo International Inc. engages in the sale of new automobiles, auto parts, and accessories in the People s Republic of China. It also provides automobile repair and maintenance services, as well as automobile leasing services. The company offers customer assistance with procuring automobile insurance and financing, and other automobile-related services. Its dealerships sell seven automobile brands comprising FAW-Volkswagen, Audi, FAW-Mazda, Shanghai-Volkswagen, Toyota, Chang An-Mazda, and GAC-Honda. As of October 22, 2012 , the company operated 11 franchise dealerships, 10 automobile showrooms, 1 automobile repair shop, and 1 car leasing company. Lentuo International Inc. was founded in 1994 and is based in Beijing, the People s Republic of China..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---